Celltech establishes Nordic subsidiary in Copenhagen

2002.11.06

Celltech Group plc has chosen Copenhagen as its base for expansion into the Nordic region

Celltech Group plc has chosen Copenhagen as its base for expansion into the Nordic region, the company announces in a press release today. A key reason for choosing this area is the opportunity to create a network with other biotech companies around the Medicon Valley. Celltech chose the Medicon Valley and Copenhagen due to the large concentration of biotech companies in this area as well as Copenhagen’s central location in Europe with excellent flight connections and easy access to the airport. Also included in this decision was the advantage of a flexible labour market as well as the fact that Celltech management found Copenhagen to be a beautiful city.

“Transport-wise, Copenhagen offers superb connections to London, the Nordic countries, and the rest of Europe,” says Jørgen Damsbo Andersen, who has been investigating Celltech Nordic Regional Office possibilities since early 2002. He contacted Copenhagen Capacity and Invest in Denmark to assist with analysing location possibilities using their expertise when considering Copenhagen. Jørgen Damsbo Andersen has been appointed Managing Director of Celltech Nordic. He will be responsible for establishing Celltech’s Nordic operations, including recruitment of an experienced team of sales representatives and support staff.

About Celltech

Celltech is a leading European biotechnology company, with a substantial long-term commitment to innovative drug discovery and development. The Group consists of two operating companies: Celltech R&D, the discovery and development business; and Celltech Pharmaceuticals, the marketing, distribution, and manufacturing business.

Celltech R&D, with an annual budget of well over 135n euro, is pursuing a dual-pipeline approach, focused in its core areas of autoimmune and inflammatory disorders and cancer. Celltech Pharmaceuticals will provide a platform for the future commercialisation of specialised products from Celltech's development pipeline.

Celltech’s turnover is almost 540m euro p.a. Headquartered in the UK, the Group consists of operating companies in the USA, UK, Spain, France, Germany, Belgium and Ireland. The Nordic subsidiary, Celltech Nordic, is a part of a new European expansion with a view to being represented in all major European markets in the near future.

About Cookies

Information about cookies

A cookie is a small text file, which is placed on your computer or other devices.
It makes it possible for us to recognize your computer and gather information about
which pages and functions are visited with your computer. Cookies contain only anonymous
information.

Cookies are used by most websites and are in many cases essential for the website
to work properly.

Cookies on this website

We use cookies on this website for various purposes related to functionality, web
analysis and marketing. We use cookies primarily to gather statistics about the
users’ visits. The information gathered is used to improve the user experience on
our website.

You can read more about the cookies we use under the three tabs. The cookies are
divided into categories and you will find information about their name, expiration,
purpose and company.

No to cookies

If you wish to decline the use of cookies now or in the future, you can change the
permission in your browser settings. You block for the use of cookies from this
and other websites by adding the domain under settings in your browser.

What happens if I say no to cookies?

If you choose to decline cookies in your browser, your device will not be tracked
when you browse the internet. However, please note that by declining cookies you
will automatically also not allow a lot of functionality on various websites and
they may not work correctly.